BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

803 related articles for article (PubMed ID: 9114432)

  • 1. Enhancing effects of (2S,3S,4R)-1-O-(alpha-D-galactopyranosyl)-2-(N-hexacosanoylamino) -1,3,4-octadecanetriol (KRN7000) on antigen-presenting function of antigen-presenting cells and antimetastatic activity of KRN7000-pretreated antigen-presenting cells.
    Yamaguchi Y; Motoki K; Ueno H; Maeda K; Kobayashi E; Inoue H; Fukushima H; Koezuka Y
    Oncol Res; 1996; 8(10-11):399-407. PubMed ID: 9114432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-S-GalCer: synthesis and evaluation for iNKT cell stimulation.
    Blauvelt ML; Khalili M; Jaung W; Paulsen J; Anderson AC; Brian Wilson S; Howell AR
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6374-6. PubMed ID: 18993065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oyster (Crassostrea gigas) hydrolysates produced on a plant scale have antitumor activity and immunostimulating effects in BALB/c mice.
    Wang YK; He HL; Wang GF; Wu H; Zhou BC; Chen XL; Zhang YZ
    Mar Drugs; 2010 Feb; 8(2):255-68. PubMed ID: 20390104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total synthesis of α-1C-galactosylceramide, an immunostimulatory C-glycosphingolipid, and confirmation of the stereochemistry in the first-generation synthesis.
    Liu Z; Byun HS; Bittman R
    J Org Chem; 2011 Nov; 76(21):8588-98. PubMed ID: 21958232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intramolecular nitrogen delivery for the synthesis of C-glycosphingolipids. Application to the C-glycoside of the immunostimulant KRN7000.
    Altiti AS; Mootoo DR
    Org Lett; 2014 Mar; 16(5):1466-9. PubMed ID: 24559301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syntheses and biological activities of KRN7000 analogues having aromatic residues in the acyl and backbone chains with varying stereochemistry.
    Park JJ; Lee JH; Seo KC; Bricard G; Venkataswamy MM; Porcelli SA; Chung SK
    Bioorg Med Chem Lett; 2010 Feb; 20(3):814-8. PubMed ID: 20061147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetic analysis of HLA class II alleles in Japanese patients with melanoma.
    Kageshita T; Naruse T; Hirai S; Ono T; Horikoshi T; Nakagawa H; Tamaki K; Hayashibe K; Ichihashi M; Nakayama J; Hori Y; Ozawa A; Miyahara M; Ohkido M; Inoko H
    Tissue Antigens; 1997 May; 49(5):466-70. PubMed ID: 9174138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Identification of biologically active sites in laminin an extracellular matrix protein].
    Nomizu M
    Yakugaku Zasshi; 1998 Dec; 118(12):566-80. PubMed ID: 9921265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel stimulates melanogenesis in B16-F1 melanoma cells.
    Bicamumpaka C; Pagé M
    Anticancer Res; 1998; 18(6A):4101-4. PubMed ID: 9891452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active specific immunotherapy in hepatic metastasis.
    Schlag PM; Milleck J; Liebrich W
    Ann Ital Chir; 1996; 67(6):783-91. PubMed ID: 9125691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of single and multiple administration of an O6-benzylguanine/temozolomide combination: an evaluation in a human melanoma xenograft model.
    Wedge SR; Porteous JK; Newlands ES
    Cancer Chemother Pharmacol; 1997; 40(3):266-72. PubMed ID: 9219512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated cytotoxicity for melanoma tumor cells: detection by a (3H) proline release assay.
    Saal JG; Rieber EP; Riethmüller G
    Scand J Immunol; 1976; 5(5):455-66. PubMed ID: 959779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autologous human dendriphages pulsed with synthetic or natural tumor peptides elicit tumor-specific CTLs in vitro.
    Tjandrawan T; Martin DM; Maeurer MJ; Castelli C; Lotze MT; Storkus WJ
    J Immunother; 1998 Mar; 21(2):149-57. PubMed ID: 9551367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonlethal gamma radiation displays similar cytoplasmic rearrangements as 12(S)-HETE.
    Haddad M; Taylor JD
    Adv Exp Med Biol; 1997; 400B():889-94. PubMed ID: 9547643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New immunotherapy for patients with neoplasms using tumor antigens recognized by T lymphocytes].
    Kawakami Y
    Nihon Naika Gakkai Zasshi; 1998 Dec; 87(12):2536-44. PubMed ID: 9922678
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of Ku autoantigen binding activity to the E2F motif after ultraviolet B irradiation of melanocytic cells.
    Pedley J; Pettit A; Parsons PG
    Melanoma Res; 1998 Dec; 8(6):471-81. PubMed ID: 9918408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of the aqueous-alcoholic extracts from unripe cotton ball of Gossypium indicum.
    Choi JJ; Yoon KN; Lee SK; Lee YH; Park JH; Kim WY; Kim JK; Kim WK
    Arch Pharm Res; 1998 Jun; 21(3):266-72. PubMed ID: 9875442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose adjuvant interferon therapy for melanoma.
    Licata AG
    Dermatol Nurs; 1998 Oct; 10(5):334-6. PubMed ID: 9873271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines and other adjuvant therapies for melanoma.
    Wolchok JD; Livingston PO; Houghton AN
    Hematol Oncol Clin North Am; 1998 Aug; 12(4):835-48, vii. PubMed ID: 9759582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis in malignant melanoma.
    Stadelmann WK; Reintgen DS
    Hematol Oncol Clin North Am; 1998 Aug; 12(4):767-96, vi. PubMed ID: 9759578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.